4//SEC Filing
Wilson Mark Andrew 4
Accession 0001209191-23-058860
CIK 0000906709other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:05 PM ET
Size
5.6 KB
Accession
0001209191-23-058860
Insider Transaction Report
Form 4
Wilson Mark Andrew
Chief Legal Officer
Transactions
- Award
Stock Option
2023-12-13+325,000→ 325,000 totalExercise: $0.50Exp: 2031-12-12→ Common Stock (325,000 underlying)
Footnotes (1)
- [F1]This stock option vests over three years from the date of grant, (December 13, 2023) in equal monthly installments based on continued service.
Documents
Issuer
NEKTAR THERAPEUTICS
CIK 0000906709
Entity typeother
Related Parties
1- filerCIK 0001808356
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 6:05 PM ET
- Size
- 5.6 KB